(NASDAQ: LIN) Linde's forecast annual revenue growth rate of 4.16% is not forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 4.59%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.61%.
Linde's revenue in 2025 is $33,504,000,000.On average, 26 Wall Street analysts forecast LIN's revenue for 2025 to be $15,985,529,669,620, with the lowest LIN revenue forecast at $15,422,389,260,040, and the highest LIN revenue forecast at $17,109,008,795,200. On average, 26 Wall Street analysts forecast LIN's revenue for 2026 to be $16,791,950,471,730, with the lowest LIN revenue forecast at $15,901,945,811,150, and the highest LIN revenue forecast at $18,069,989,693,140.
In 2027, LIN is forecast to generate $17,699,699,191,650 in revenue, with the lowest revenue forecast at $16,388,973,545,140 and the highest revenue forecast at $19,090,273,105,190.